Eva Hofsli
About
Eva Hofsli is a scholar working on Oncology, Epidemiology and Molecular Biology.
According to data from OpenAlex, Eva Hofsli has authored 60 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 16 papers in Epidemiology and 15 papers in Molecular Biology. Recurrent topics in Eva Hofsli's work include Neuroendocrine Tumor Research Advances (15 papers), Colorectal Cancer Treatments and Studies (10 papers) and Lung Cancer Research Studies (10 papers). Eva Hofsli is often cited by papers focused on Neuroendocrine Tumor Research Advances (15 papers), Colorectal Cancer Treatments and Studies (10 papers) and Lung Cancer Research Studies (10 papers). Eva Hofsli collaborates with scholars based in Norway, Sweden and Denmark. Eva Hofsli's co-authors include Halfdan Sørbye, Pia Österlund, Svein Dueland, Marianne G. Guren, Seppo W. Langer, Wenche Sjursen, Ulrich Knigge, Eva Tiensuu Janson, Lene Weber Vestermark and Matteo Biagini and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
In The Last Decade
Eva Hofsli
55 papers receiving 1.5k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Eva Hofsli Norway | 18 | 1.0k | 810 | 512 | 294 | 190 | 60 | 1.5k | ||
| Massimo Malagó Germany | 21 | 434 0.4× | 635 0.8× | 166 0.3× | 276 0.9× | 169 0.9× | 36 | 1.7k | ||
| Driss Chaoui France | 16 | 478 0.5× | 177 0.2× | 96 0.2× | 318 1.1× | 43 0.2× | 29 | 1.1k | ||
| Steven W. Warmann Germany | 25 | 390 0.4× | 196 0.2× | 225 0.4× | 686 2.3× | 177 0.9× | 144 | 1.9k | ||
| E H Cooper United Kingdom | 20 | 523 0.5× | 234 0.3× | 103 0.2× | 310 1.1× | 59 0.3× | 39 | 1.2k | ||
| Edwina Baskin-Bey United States | 22 | 374 0.4× | 402 0.5× | 58 0.1× | 292 1.0× | 217 1.1× | 51 | 1.6k | ||
| Chad M. Michener United States | 24 | 382 0.4× | 138 0.2× | 70 0.1× | 411 1.4× | 225 1.2× | 98 | 1.6k | ||
| P.H.B. Willemse Netherlands | 22 | 486 0.5× | 128 0.2× | 82 0.2× | 339 1.2× | 113 0.6× | 62 | 1.4k | ||
| Jennifer H. Foster United States | 15 | 262 0.3× | 67 0.1× | 545 1.1× | 429 1.5× | 282 1.5× | 63 | 1.1k | ||
| Rachel Goodwin Canada | 20 | 894 0.9× | 101 0.1× | 57 0.1× | 212 0.7× | 198 1.0× | 87 | 1.2k |
Countries citing papers authored by Eva Hofsli
Since
Specialization
Citations
This map shows the geographic impact of Eva Hofsli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Hofsli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Hofsli more than expected).
Fields of papers citing papers by Eva Hofsli
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Eva Hofsli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Hofsli. The network helps show where Eva Hofsli may publish in the future.
Co-authorship network of co-authors of Eva Hofsli
This figure shows the co-authorship network connecting the top 25 collaborators of Eva Hofsli. A scholar is included among the top collaborators of Eva Hofsli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Hofsli. Eva Hofsli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Sørbye, Halfdan, Geir Olav Hjortland, Lene Weber Vestermark, et al.. (2025). Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study. British Journal of Cancer. 133(3). 316–324.
2.
Mjelle, Robin, Ola Magne Vagnildhaug, Trude R. Balstad, et al.. (2025). Serum miRNA Signatures in Cancer Cachexia Depend on Systemic Inflammation. Current Oncology. 32(11). 620–620.
3.
Mjelle, Robin, et al.. (2024). Serum small RNAs in metastatic colorectal cancer predict response to chemotherapy and characterize high-risk patients. Molecular Cancer. 23(1). 133–133.
4.
Knappskog, Stian, Tobias Grob, Ursula Amstutz, et al.. (2023). Mutation Spectrum in Liquid Versus Solid Biopsies From Patients With Advanced Gastroenteropancreatic Neuroendocrine Carcinoma. JCO Precision Oncology. 7(7). e2200336–e2200336.
5.
Raj, Sunil Xavier, et al.. (2023). Design, Development, and Evaluation of an mHealth App for Reporting of Side Effects During Cytostatic Treatment: Usability Test and Interview Study. JMIR Formative Research. 7. e47374–e47374.
6.
Hansen, Rune, et al.. (2023). Treatment of Liver Metastases With Focused Ultrasound and Microbubbles in Patients With Colorectal Cancer Receiving Chemotherapy. Ultrasound in Medicine & Biology. 49(9). 2081–2088.
7.
Liposits, Gábor, Halla Skúladóttir, Jesper Ryg, et al.. (2022). The Prognostic Value of Pre-Treatment Circulating Biomarkers of Systemic Inflammation (CRP, dNLR, YKL-40, and IL-6) in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy—The Randomized NORDIC9-Study. Journal of Clinical Medicine. 11(19). 5603–5603.
8.
Meltzer, Sebastian, Anne Negård, Hanne Hamre, et al.. (2022). Early radiologic signal of responsiveness to immune checkpoint blockade in microsatellite-stable/mismatch repair-proficient metastatic colorectal cancer. British Journal of Cancer. 127(12). 2227–2233.
9.
Sørbye, Halfdan, Stian Knappskog, Tobias Grob, et al.. (2022). 890MO Mutation spectrum in liquid versus solid biopsies from advanced digestive neuroendocrine carcinoma patients. Annals of Oncology. 33. S955–S955.
10.
Liposits, Gábor, Jesper Ryg, Halla Skúladóttir, et al.. (2022). Prognostic value of baseline functional status measures and geriatric screening in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy – The randomized NORDIC9-study. Journal of Geriatric Oncology. 14(1). 101408–101408.
11.
Berglund, Åke, Marianne G. Guren, Eva Hofsli, et al.. (2022). Sex hormones and sperm parameters after adjuvant oxaliplatin-based treatment for colorectal cancer. Cancer Treatment and Research Communications. 31. 100517–100517.
12.
Hatlevoll, Ingunn, Line Oldervoll, Arne Wibe, et al.. (2020). Physical exercise during adjuvant chemotherapy for colorectal cancer—a non-randomized feasibility study. Supportive Care in Cancer. 29(6). 2993–3008.
13.
Mjelle, Robin, Wenche Sjursen, Liv Thommesen, Pål Sætrom, & Eva Hofsli. (2019). Small RNA expression from viruses, bacteria and human miRNAs in colon cancer tissue and its association with microsatellite instability and tumor location. BMC Cancer. 19(1). 161–161.
14.
Sørbye, Halfdan, Staffan Welin, Seppo W. Langer, et al.. (2013). Ki-67 Proliferative Index Predicts Response to Chemotherapy and Survival in 252 Patients with High-Grade Gastrointestinal Neuroendocrine Carcinoma (WHO G3). Pancreas. 42(2). 382–382.
15.
Sjursen, Wenche, Eva Hofsli, Lars Engebretsen, et al.. (2013). Mutation screening in a Norwegian cohort with pheochromocytoma. Familial Cancer. 12(3). 529–535.
16.
Sørbye, Halfdan, Staffan Welin, Seppo W. Langer, et al.. (2012). Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study. Annals of Oncology. 24(1). 152–160.
17.
Tranø, G., Wenche Sjursen, Hans H. Wasmuth, Eva Hofsli, & Lars J. Vatten. (2010). Performance of clinical guidelines compared with molecular tumour screening methods in identifying possible Lynch syndrome among colorectal cancer patients: a Norwegian population-based study. British Journal of Cancer. 102(3). 482–488.
18.
Thommesen, Liv, Kristin G. Nørsett, Arne K. Sandvik, Eva Hofsli, & Astrid Lægreid. (2000). Regulation of Inducible cAMP Early Repressor Expression by Gastrin and Cholecystokinin in the Pancreatic Cell Line AR42J. Journal of Biological Chemistry. 275(6). 4244–4250.
19.
Hofsli, Eva, et al.. (1989). Recombinant Tumour Necrosis Factor (TNF) Fixed to Cell Monolayers Retains Its Cytotoxic and Growth‐Stimulatory Activity. Scandinavian Journal of Immunology. 29(1). 57–63.
20.
Hofsli, Eva, Oddmund Bakke, Unni Nonstad, & Terje Espevik. (1989). A flow cytometric and immunofluorescence microscopic study of tumor necrosis factor production and localization in human monocytes. Cellular Immunology. 122(2). 405–415.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Massimo Malagó Breakdown of academic impact, for papers by Driss Chaoui Breakdown of academic impact, for papers by Steven W. Warmann Breakdown of academic impact, for papers by E H Cooper Breakdown of academic impact, for papers by Edwina Baskin-Bey Breakdown of academic impact, for papers by Chad M. Michener Breakdown of academic impact, for papers by P.H.B. Willemse Breakdown of academic impact, for papers by Jennifer H. Foster Breakdown of academic impact, for papers by Rachel Goodwin